Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Intravitreal triamcinolone acetonide injection 4 mg vs sham

Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes

It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes use of IOP‐lowering medications ‐ 24 months compared with sham (very low certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 21.6 [1.32, 354.7]
Studies not reported
Very low

Intravitreal triamcinolone acetonide injection 4 mg vs macular laser

Use of IOP‐lowering medications · macular edema in diabetes

Intravitreal triamcinolone acetonide injection 4 mg probably leads to higher use of IOP‐lowering medications ‐ 9 to 24 months compared with macular laser (moderate certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 3.92 [2.59, 5.96]
Studies not reported
Moderate